Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
SIMRIS-B.STthis companySimris Alg AB (publ)	SEK 0.11	-1.35×	-76.69×	22.32×	-7.06×	-180.1%	-1940.7%	-1940.7%	-1660.1%	5704.5%	-22.5%	-45.1%	-186.55×	-4.98×	-71.07×	0.66×	0.0%	3	-0.04	1	D+
ACOU.STAcouSort AB	SEK 3.12	-4.42×	3.27×	7.79×	-3.29×	-1703.2%	-211.6%	-211.6%	-177.3%	-74.6%	-89.0%	-32.4%	0×	0.44×	-10.85×	8.19×	0.0%	2	-4.93	1	D+
ATORX.STAlligator Bioscience AB (publ)	SEK 0.01	-0.18×	1.35×	18.04×	0.08×	6004.4%	-10665.2%	-23780.5%	-9990.3%	-748.7%	-244.4%	-1697.7%	6.29×	0.16×	-2.76×	0.88×	0.0%	1	-24.71	2	B-
EXPRS2.STExpreS2ion Biotech Holding AB (publ)	SEK 0.91	-1.19×	1.27×	12.37×	0×	1336.2%	-1171.5%	-1444.4%	-1041.4%	-106.7%	-121.9%	-90.4%	0.06×	0.88×	-117.12×	2.04×	0.0%	2	-2.66	3	B
MODTX.STModus Therapeutics Holding AB	SEK 0.17	-1.01×	2.1×	0×	-0.42×	4.5%	0.0%	0.0%	0.0%	-204.4%	-200.3%	-94.9%	0×	0.63×	-45.3×	3.51×	0.0%	1	-38.3	2	C
NEWBRY.STNewbury Pharmaceuticals AB (publ)	SEK 1.70	-3.35×	0×	1.79×	0×	-52637.2%	24.8%	-48.4%	-53.7%	0.0%	0.0%	0.0%	0×	0×	0×	0×	0.0%	1	0.45	1	D+
Peer median	—	-1.19×	1.35×	7.79×	0×	4.5%	-211.6%	-211.6%	-177.3%	-106.7%	-121.9%	-90.4%	0×	0.44×	-10.85×	2.04×	0.0%	1	-4.93	2	—